子宫肌瘤药物和微创治疗的现况和趋向

The current situation and trend about drug therapy and minimal invasive surgery of uterine fibroids

子宫肌瘤是妇科第一瘤,发病率高,但并非均要手术治疗。药物治疗和微创治疗对控制子宫肌瘤症状、纠正贫血、延缓肌瘤发展、改善孕育和生活质量、避免手术切除子宫起到积极作用。子宫肌瘤治疗方法和概念在逐渐转变,治疗模式从有创(大创、重创)-微创-无创转变。子宫肌瘤患者也应重视肿瘤生殖医学的新概念。

Uterine fibroids, with high incidence, are the most common gynecologic tumors. However, surgery is not the gold standard for the treatment of uterine myomas. Practices in drug treatment and minimal invasive surgery have showed that they provide significant improvements for controlling symptoms, correcting anemia, delaying enlargement, improving reproduetivity and life quality without hysterectomy. Alternatively, concept and therapeutic methods about uterine fibroids are changing. The therapeutic mode has been changing from invasive, minimal invasive to noninvasive treatment. In that case, it is important to put emphasis on oncologic reproductivity in patients with uterine fibroids.